Adipokine Chemerin Bridges Metabolic Dyslipidemia and Alveolar Bone Loss in Mice

被引:49
|
作者
Ramos-Junior, Erivan S. [1 ]
Leite, Gisele A. [2 ]
Carmo-Silva, Cecilia C. [1 ]
Taira, Thaise M. [2 ]
Neves, Karla B. [3 ]
Colon, David F. [3 ]
da Silva, Lea A. B. [2 ]
Salvador, Sergio L. [4 ]
Tostes, Rita C. [3 ]
Cunha, Fernando Q. [3 ]
Fukada, Sandra Y. [1 ]
机构
[1] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Chem & Phys, Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Pediat Dent, Sao Paulo, Brazil
[3] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil
[4] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Clin Analyses, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
ADIPOKINE; CHEMERIN; OSTEOCLASTS; METABOLISM; DYSLIPIDEMIA; OSTEOCLAST DIFFERENTIATION; RHEUMATOID-ARTHRITIS; INFLAMMATION; OBESITY; CELLS; RECEPTOR; DISEASE; CHEMR23; LIGAND; ADIPOGENESIS;
D O I
10.1002/jbmr.3072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chemerin is an adipokine that regulates adipogenesis and metabolic functions of mature adipocytes mainly through the activation of chemokine-like receptor 1 (CMKLR1). Elevated levels of chemerin have been found in individuals with obesity, type 2 diabetes, and osteoporosis. This adipokine was identified as an inflammatory and metabolic syndrome marker. Considering that the association between metabolic syndrome and bone health remains unclear, the present study aimed to clarify the role of chemerin in the pathophysiology of bone loss induced by dyslipidemia, particularly modulating osteoclastogenesis. In vitro analyses showed a downregulation of CMKLR1 at the early stage of differentiation and a gradual increase at late stages. Strikingly, chemerin did not modify osteoclast differentiation markers or osteoclast formation; however, it increased the actin-ring formation and bone resorption activity in mature osteoclasts. The increased bone resorption activity induced by chemerin was effectively inhibited by CMKLR1 antagonist (CCX832). Chemerin boosting mature osteoclast activity involves ERK5 phosphorylation. Moreover, two models of dyslipidemia (high-fat diet [HFD]-treated C57/BL6 and db/db mice) exhibited significantly increased level of chemerin in the serum and gingival tissue. Morphometric analysis showed that HFD-treated and db/db mice exhibited increased alveolar bone loss compared to respective control mice, which was associated with an up-regulation of chemerin, CMKLR1 and cathepsin K mRNA expression in the gingival tissue. The treatment of db/db mice with CCX832 effectively inhibited bone loss. Antagonism of chemerin receptor also inhibited the expression of cathepsin K in the gingival tissue. Our results show that chemerin not only increases osteoclasts activity in vitro, but also that increased level of chemerin in dyslipidemic mice plays a critical role in bone homeostasis. (c) 2016 American Society for Bone and Mineral Research.
引用
收藏
页码:974 / 984
页数:11
相关论文
共 50 条
  • [1] Adipokine chemerin overexpression in trophoblasts leads to dyslipidemia in pregnant mice: implications for preeclampsia
    Lunbo Tan
    Zijun Ouyang
    Zhilong Chen
    Fen Sun
    Haichun Guo
    Feng Wang
    Monique Mulder
    Yuan Sun
    Xifeng Lu
    Jian V. Zhang
    A. H. Jan Danser
    Koen Verdonk
    Xiujun Fan
    Qing Yang
    Lipids in Health and Disease, 22
  • [2] Adipokine chemerin overexpression in trophoblasts leads to dyslipidemia in pregnant mice: implications for preeclampsia
    Tan, Lunbo
    Ouyang, Zijun
    Chen, Zhilong
    Sun, Fen
    Guo, Haichun
    Wang, Feng
    Mulder, Monique
    Sun, Yuan
    Lu, Xifeng
    Zhang, Jian V.
    Danser, A. H. Jan
    Verdonk, Koen
    Fan, Xiujun
    Yang, Qing
    LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
  • [3] Chemerin: An inflammatory adipokine involved in metabolic diseases
    Sell, Henrike
    Poitou, Christine
    CAHIERS DE NUTRITION ET DE DIETETIQUE, 2014, 49 (02): : 88 - 92
  • [4] Chemerin: a multifaceted adipokine involved in metabolic disorders
    Helfer, Gisela
    Wu, Qing-Feng
    JOURNAL OF ENDOCRINOLOGY, 2018, 238 (02) : R79 - R94
  • [5] ALVEOLAR BONE LOSS IN MICE
    SHANLEY, DB
    JOURNAL OF DENTAL RESEARCH, 1971, 50 (05) : 1174 - &
  • [6] Chemerin is a novel adipokine associated with obesity and metabolic syndrome
    Bozaoglu, Kiymet
    Bolton, Kristy
    McMillan, Janine
    Zimmet, Paul
    Jowett, Jeremy
    Collier, Greg
    Walder, Ken
    Segal, David
    ENDOCRINOLOGY, 2007, 148 (10) : 4687 - 4694
  • [7] Chemerin is a novel adipokine associated with obesity and metabolic syndrome
    Bozaoglu, K.
    Segal, D.
    Bolton, K.
    McMillan, J.
    Jowett, J.
    Zirmuet, P.
    Collier, G.
    Walder, K.
    DIABETOLOGIA, 2007, 50 : S57 - S57
  • [8] ALVEOLAR BONE LOSS IN A STRAIN OF MICE
    MESSER, HH
    JOURNAL OF PERIODONTAL RESEARCH, 1980, 15 (02) : 193 - 205
  • [9] INHIBITION BY CHLORHEXIDINE OF ALVEOLAR BONE LOSS IN MICE
    MESSER, HH
    DOUGLAS, WH
    JOURNAL OF PERIODONTAL RESEARCH, 1980, 15 (06) : 646 - 649
  • [10] Adipokine Chemerin Stimulates Progression of Atherosclerosis in ApoE-/- Mice
    Liu, Huadong
    Xiong, Wei
    Luo, Yu
    Chen, Hua
    He, Yaqiong
    Cao, Yuanzhi
    Dong, Shaohong
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019